HER2 Support Group Forums - View Single Post - Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients

News · 12-08-2009, 11:10 PM

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed a Phase 3 clinical trial of Lymphoseek® (NEO3-05) with positive results.

More...

12-08-2009, 11:10 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,105	Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed a Phase 3 clinical trial of Lymphoseek® (NEO3-05) with positive results. More...